Connecting Research and Experts with Journalists

• share
• favorite_border

Combining a breast cancer patient's clinical characteristics with a genomic profile of her tumor may provide important information for predicting an individual patient's prognosis and accurately guiding treatment options, according to a new study led by researchers in the Duke Comprehensive Cancer Center (DCCC) and Duke's Institute for Genome Sciences & Policy (IGSP).

• share
• favorite_border

Patients with early stage breast cancer who were treated with lumpectomy plus radiation may have a better chance of survival compared with those who underwent mastectomy, according to Duke Medicine research.

• share
• favorite_border

A father's obesity is one factor that may influence his children's health and potentially raise their risk for diseases like cancer, according to new research from Duke Medicine.

• share
• favorite_border

Researchers are building complex mathematical models to understand cancer's evolution and how to treat it

• share
• favorite_border

Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research led by Duke Cancer Institute.

• share
• favorite_border

Kimberly Blackwell, M.D., a clinical oncologist at Duke Cancer Institute and one of the country’s leading breast cancer researchers, is included in this year’s roster of TIME magazine’s 100 most influential people.

• share
• favorite_border

A protein produced by mast cells in the immune system may predict which people infected with dengue virus will develop life-threatening complications, according to researchers at Duke Medicine and Duke-National University of Singapore (Duke-NUS).

• share
• favorite_border

Mutations in a gene that helps regulate copper and oxygen levels in eye tissue are associated with a severe form of nearsightedness, according to a study published in the American Journal of Human Genetics on May 2, 2013.

• share
• favorite_border

Continuing analysis of an HIV vaccine trial undertaken in Thailand is yielding additional information about how immune responses were triggered and why the vaccine did not protect more people.

• share
• favorite_border

A seven-year quest to understand how breast cancer cells resist treatment with the targeted therapy lapatinib has revealed a previously unknown molecular network that regulates cell death. The discovery provides new avenues to overcome drug resistance, according to researchers at Duke Cancer Institute.